Scholars Central

Review articlePublished 2020

Prevalence, Risk Factors And Relationship Of Pruritus With Blood Lead Level In Chronic Kidney Disease On Maintenance Hemodialysis

Authors: Nafesa Mohammed Kamal, Essam Eldin Mahmoud Lotfy, Hatem Elmaghawry Mohammed Elshiekh, Lamiaa Abd Elwahab Mohammed, Ahmed Maher Elsayed.

Systematic Reviews in Pharmacy

Volume 11 · Issue 12 · Pages 558–562

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Background: one of the most nearly daily compromising symptoms in hemodialysis patients is skin itching. Blood lead level (BLLs) may have a risk factor that increase the intensity of hemodialysis pruritus. Objective: To evaluate the prevalence of pruritus and its relationship with blood lead level in renal patients maintained on hemodialysis. Patients and Method: Cross -sectional Study carried on100 patients with End stage renal disease (ESRD) divided into Group I; low BLLs (<15 µg/dl) included 56 patients, Group II; High normal BLLs (15 ≤ BLL< 25 µg/dl) included 32 patients and Group III; High BLLs (≥ 25 µg/dl) included 12 patients. All subjects were evaluated for kidney and liver function, electrolytes, CBC, estimation of GFR by MDRD equation, and Lead level in serum and dialysis water. Results: we found in this study that prevalence of pruritus was (19%), BLLs have a high statistically significant positive relation to HD duration (P<0.001) & I-PTH(P<0.001) & pruritus (P< 0.001) & visual analogue scale (VAS) (P<0.044) and high significant negative relation to serum albumin (P< 0.015) & hemoglobin(P<0.001). Also, Serum Lead (µg/dL) is an independent predictor for incidence of uremic pruritus [odds ratio (OR) =1.207; 95% by Multiple logistic regression analysis Conclusions: pruritus prevalence was (19%), blood lead level is highly related to pruritus and independent risk factor with HD duration for early onset and progression of itching in chronic haemodialysis patients. So we recommend serum lead investigation in these patients for early detection and reduction of its dermatological and psychological morbidity.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Systematic Reviews in Pharmacy.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalSystematic Reviews in Pharmacy
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Nafesa Mohammed Kamal”
  • BylineArticles whose byline prints “Essam Eldin Mahmoud Lotfy”
  • BylineArticles whose byline prints “Hatem Elmaghawry Mohammed Elshiekh”
  • BylineArticles whose byline prints “Lamiaa Abd Elwahab Mohammed”
  • BylineArticles whose byline prints “Ahmed Maher Elsayed.”